Reneo Pharmaceuticals Inc
NASDAQ:RPHM
Income Statement
Earnings Waterfall
Reneo Pharmaceuticals Inc
Revenue
|
0
USD
|
Operating Expenses
|
-83.1m
USD
|
Operating Income
|
-83.1m
USD
|
Other Expenses
|
5.7m
USD
|
Net Income
|
-77.4m
USD
|
Income Statement
Reneo Pharmaceuticals Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(20)
|
(22)
|
(28)
|
(35)
|
(40)
|
(46)
|
(49)
|
(50)
|
(54)
|
(57)
|
(66)
|
(73)
|
(83)
|
|
Selling, General & Administrative |
(4)
|
(4)
|
(6)
|
(9)
|
(12)
|
(14)
|
(15)
|
(15)
|
(16)
|
(18)
|
(20)
|
(23)
|
(26)
|
|
Research & Development |
(16)
|
(18)
|
(21)
|
(26)
|
(28)
|
(32)
|
(34)
|
(34)
|
(38)
|
(39)
|
(46)
|
(49)
|
(57)
|
|
Operating Income |
(20)
N/A
|
(22)
-14%
|
(28)
-25%
|
(35)
-28%
|
(40)
-12%
|
(46)
-15%
|
(49)
-7%
|
(50)
-2%
|
(54)
-8%
|
(57)
-6%
|
(66)
-15%
|
(73)
-11%
|
(83)
-14%
|
|
Pre-Tax Income | ||||||||||||||
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
4
|
5
|
6
|
|
Pre-Tax Income |
(19)
N/A
|
(22)
-14%
|
(28)
-25%
|
(35)
-28%
|
(40)
-12%
|
(46)
-15%
|
(49)
-7%
|
(49)
-1%
|
(52)
-6%
|
(54)
-4%
|
(61)
-13%
|
(67)
-10%
|
(77)
-15%
|
|
Net Income | ||||||||||||||
Income from Continuing Operations |
(19)
|
(22)
|
(28)
|
(35)
|
(40)
|
(46)
|
(49)
|
(49)
|
(52)
|
(54)
|
(61)
|
(67)
|
(77)
|
|
Net Income (Common) |
(19)
N/A
|
(22)
-14%
|
(28)
-25%
|
(35)
-28%
|
(40)
-12%
|
(46)
-15%
|
(49)
-7%
|
(49)
-1%
|
(52)
-6%
|
(54)
-4%
|
(61)
-13%
|
(67)
-10%
|
(77)
-15%
|
|
EPS (Diluted) |
-0.8
N/A
|
-0.92
-15%
|
-1.3
-41%
|
-1.45
-12%
|
-1.63
-12%
|
-1.86
-14%
|
-1.98
-6%
|
-1.99
-1%
|
-2.12
-7%
|
-2.15
-1%
|
-2.02
+6%
|
-1.99
+1%
|
-2.52
-27%
|